532983 Stock Overview
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
RPG Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2,525.75 |
| 52 Week High | ₹2,976.70 |
| 52 Week Low | ₹1,363.90 |
| Beta | 0.44 |
| 1 Month Change | 8.47% |
| 3 Month Change | 1.58% |
| 1 Year Change | 53.33% |
| 3 Year Change | 338.73% |
| 5 Year Change | 765.58% |
| Change since IPO | 5,659.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532983 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 5.0% | 3.2% | 2.4% |
| 1Y | 53.3% | 18.4% | 5.8% |
Return vs Industry: 532983 exceeded the Indian Pharmaceuticals industry which returned 18.4% over the past year.
Return vs Market: 532983 exceeded the Indian Market which returned 5.8% over the past year.
Price Volatility
| 532983 volatility | |
|---|---|
| 532983 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 532983 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532983's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,270 | Yugal Kishor Sikri | www.rpglifesciences.com |
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India.
RPG Life Sciences Limited Fundamentals Summary
| 532983 fundamental statistics | |
|---|---|
| Market cap | ₹41.85b |
| Earnings (TTM) | ₹791.30m |
| Revenue (TTM) | ₹6.37b |
52.9x
P/E Ratio6.6x
P/S RatioIs 532983 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532983 income statement (TTM) | |
|---|---|
| Revenue | ₹6.37b |
| Cost of Revenue | ₹2.11b |
| Gross Profit | ₹4.26b |
| Other Expenses | ₹3.47b |
| Earnings | ₹791.30m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 47.84 |
| Gross Margin | 66.82% |
| Net Profit Margin | 12.42% |
| Debt/Equity Ratio | 0% |
How did 532983 perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield30%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 18:46 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
RPG Life Sciences Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kunal Dhamesha | Emkay Global Financial Services Ltd. |
| Kameswari V. S. Chavali | FirstCall Research |